Annovis Bio Inc. (ANVS) Social Stream
ANNOVIS BIO INC (ANVS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ANVS.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-22 | 1 | $70 | $70 | $70 | $9.1 | 669.23% |
| 2022-04-08 | 1 | $26 | $26 | $26 | $9.1 | 185.71% |
| 2022-08-09 | 2 | $37 | $26 | $31.5 | $9.1 | 246.15% |
| 2023-04-04 | 3 | $72 | $26 | $46 | $9.1 | 405.49% |
| 2023-08-17 | 2 | $72 | $40 | $56 | $9.1 | 515.38% |
The Trend in the Analyst Price Target
Over the past 40 weeks, ANVS's average price target has gone up $10.
ANVS reports an average of 288.88% for its upside potential over the past 40 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-30 | 3 | 72 | 26 | 46 | 17.22 | 167.13% |
| 2023-02-08 | 3 | 72 | 26 | 46 | 19.14 | 140.33% |
| 2023-04-04 | 3 | 72 | 26 | 46 | 11.95 | 284.94% |
| 2023-08-15 | 2 | 72 | 40 | 56 | 12.83 | 336.48% |
| 2023-08-17 | 2 | 72 | 40 | 56 | 12.77 | 338.53% |
ANVS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 52 weeks, ANVS's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, ANNOVIS BIO INC's number of analysts covering the stock is higher than 17.08% of them.
- In terms of how ANNOVIS BIO INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 532.78% of that group.
- ANNOVIS BIO INC's variance in analysts' estimates is lower than -29.34% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, ANNOVIS BIO INC's average analyst price target is higher than 486.35% of them.
Stocks similar to ANNOVIS BIO INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ETNB, GRTX, and RAPT.
View All Top Stocks by Price Target
Is ANVS a Buy, Hold or Sell? See the POWR Ratings now!